Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2025-06-09 10:03 am | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Gopinathan Suma SVP, Discovery | 0 | $0 | 637,980 (Direct) | View |
Ownership | 2025-06-06 5:40 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Martens Rachel Yap VP, Partnerships & Corp Strat | 0 | $0 | 553,346 (Direct) | View |
2025-06-03 Option Award | 2025-06-03 4:25 pm | N/A 2035-06-03 | LEXICON PHARMACEUTICALS INC. | LXRX | Swain Judith L Director | 193,118 | $0 | 193,118 (Direct) | View |
2025-06-03 Option Award | 2025-06-03 4:24 pm | N/A 2035-06-03 | LEXICON PHARMACEUTICALS INC. | LXRX | Sullivan Diane E. Director | 193,118 | $0 | 193,118 (Direct) | View |
2025-06-03 Option Award | 2025-06-03 4:23 pm | N/A 2035-06-03 | LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director | 193,118 | $0 | 193,118 (Direct) | View |
2025-06-03 Option Award | 2025-06-03 4:22 pm | N/A 2035-06-03 | LEXICON PHARMACEUTICALS INC. | LXRX | Cheung Ivan Director | 193,118 | $0 | 193,118 (Direct) | View |
2025-06-03 Option Award | 2025-06-03 4:22 pm | N/A 2035-06-03 | LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director | 193,118 | $0 | 193,118 (Direct) | View |
2025-06-03 Option Award | 2025-06-03 4:21 pm | N/A 2035-06-03 | LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director | 193,118 | $0 | 193,118 (Direct) | View |
2025-06-03 Option Award | 2025-06-03 4:20 pm | N/A 2035-06-03 | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 193,118 | $0 | 193,118 (Direct) | View |
2025-05-13 Exercise | 2025-05-13 5:52 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Swain Judith L Director | 36,810 | $0 | 85,174 (Direct) | View |
2025-05-13 Exercise | 2025-05-13 5:51 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Sullivan Diane E. Director | 36,810 | $0 | 36,810 (Direct) | View |
2025-05-13 Exercise | 2025-05-13 5:50 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director | 36,810 | $0 | 203,865 (Direct) | View |
2025-05-13 Exercise | 2025-05-13 5:50 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director | 36,810 | $0 | 124,459 (Direct) | View |
2025-05-13 Exercise | 2025-05-13 5:49 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director | 36,810 | $0 | 285,174 (Direct) | View |
2025-05-13 Exercise | 2025-05-13 5:48 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 36,810 | $0 | 45,755,796 (Direct) | View |
2025-02-28 Exercise | 2025-03-03 4:33 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 46,430 | $0 | 132,068 (Direct) | View |
2025-02-28 Tax Withholding | 2025-03-03 4:33 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 17,862 | $0.67 | 132,068 (Direct) | View |
2025-02-28 Exercise | 2025-03-03 4:33 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy SVP, Human Resources | 98,956 | $0 | 253,976 (Direct) | View |
2025-02-28 Tax Withholding | 2025-03-03 4:33 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy SVP, Human Resources | 30,004 | $0.67 | 253,976 (Direct) | View |
2025-02-28 Exercise | 2025-03-03 4:32 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences | 126,814 | $0 | 508,494 (Direct) | View |
2025-02-28 Tax Withholding | 2025-03-03 4:32 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences | 43,434 | $0.67 | 508,494 (Direct) | View |
2025-02-28 Exercise | 2025-03-03 4:31 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Granowitz Craig B SVP, Chief Medical Officer | 137,934 | $0 | 304,495 (Direct) | View |
2025-02-28 Tax Withholding | 2025-03-03 4:31 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Granowitz Craig B SVP, Chief Medical Officer | 65,308 | $0.67 | 304,495 (Direct) | View |
2025-02-28 Exercise | 2025-03-03 4:30 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa SVP, IR and Corp Comm | 24,673 | $0 | 64,924 (Direct) | View |
2025-02-28 Tax Withholding | 2025-03-03 4:30 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa SVP, IR and Corp Comm | 9,096 | $0.67 | 64,924 (Direct) | View |
2025-02-28 Exercise | 2025-03-03 4:28 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T SVP, General Counsel & Secr. | 128,940 | $0 | 433,045 (Direct) | View |
2025-02-28 Tax Withholding | 2025-03-03 4:28 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T SVP, General Counsel & Secr. | 45,622 | $0.67 | 433,045 (Direct) | View |
2025-02-13 Option Award | 2025-02-18 4:22 pm | N/A 2035-02-13 | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 371,080 | $0 | 371,080 (Direct) | View |
2025-02-13 Option Award | 2025-02-18 4:22 pm | N/A 2035-02-13 | LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy SVP, Human Resources | 1,082,960 | $0 | 1,082,960 (Direct) | View |
2025-02-13 Option Award | 2025-02-18 4:21 pm | N/A 2035-02-13 | LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences | 1,255,150 | $0 | 1,255,150 (Direct) | View |
2025-02-13 Option Award | 2025-02-18 4:20 pm | N/A 2035-02-13 | LEXICON PHARMACEUTICALS INC. | LXRX | Granowitz Craig B SVP, Chief Medical Officer | 1,516,950 | $0 | 1,516,950 (Direct) | View |
2025-02-13 Option Award | 2025-02-18 4:20 pm | N/A 2035-02-13 | LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa VP, IR and Corp Comm | 961,420 | $0 | 961,420 (Direct) | View |
2025-02-13 Option Award | 2025-02-18 4:19 pm | N/A 2035-02-13 | LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T SVP, General Counsel & Secr. | 1,276,220 | $0 | 1,276,220 (Direct) | View |
2025-02-13 Option Award | 2025-02-18 4:18 pm | N/A 2035-02-13 | LEXICON PHARMACEUTICALS INC. | LXRX | Corrigan Brian SVP, Regulatory & QA | 1,121,660 | $0 | 1,121,660 (Direct) | View |
2025-02-13 Option Award | 2025-02-18 4:17 pm | N/A 2035-02-13 | LEXICON PHARMACEUTICALS INC. | LXRX | Coiante Scott M SVP, Chief Financial Officer | 1,201,780 | $0 | 1,201,780 (Direct) | View |
2025-02-13 Option Award | 2025-02-18 4:16 pm | N/A 2035-02-13 | LEXICON PHARMACEUTICALS INC. | LXRX | Exton Michael Chief Executive Officer | 3,774,480 | $0 | 3,774,480 (Direct) | View |
2025-01-02 Option Award | 2025-01-02 4:09 pm | N/A 2035-01-02 | LEXICON PHARMACEUTICALS INC. | LXRX | Coiante Scott M SVP, Chief Financial Officer | 230,000 | $0 | 230,000 (Direct) | View |
Ownership | 2025-01-02 4:06 pm | N/A 2035-01-02 | LEXICON PHARMACEUTICALS INC. | LXRX | Coiante Scott M SVP, Chief Financial Officer | 0 | $0 | 230,000 (Direct) | View |
Ownership | 2024-12-16 7:00 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Artal Participations S.a r.l. Director 10% Owner | 0 | $0 | 136,180,481 (Direct) | View |
2024-12-02 Option Award | 2024-12-02 5:41 pm | N/A 2034-12-02 | LEXICON PHARMACEUTICALS INC. | LXRX | Cheung Ivan Director | 186,685 | $0 | 186,685 (Direct) | View |
Ownership | 2024-10-07 4:58 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa VP, IR and Corp Strategy | 0 | $0 | 378,040 (Direct) | View |
2024-08-12 Option Award | 2024-08-12 08:40 am | N/A 2034-08-12 | LEXICON PHARMACEUTICALS INC. | LXRX | Corrigan Brian SVP, Regulatory & QA | 200,000 | $0 | 200,000 (Direct) | View |
Ownership | 2024-07-29 5:31 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Siren L.L.C. Invus Global Management LLC Director 10% Owner | 0 | $0 | 38,918,903 (Indirect) | View |
2024-07-08 Option Award | 2024-07-08 5:27 pm | N/A 2034-07-08 | LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L President and COO | 307,000 | $0 | 307,000 (Direct) | View |